The Milan Cell and Gene Center of Excellence at AGC Biologics will produce LVV material for Treg cell therapy candidates.

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy ...

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Hualong ...

The FDA granted rare pediatric disease designation for OCU410ST, a gene therapy designed to treat ABCA4-associated ...

Dengue Vaccines Market Projected to Grow from USD 90 Million in 2025 to Nearly USD 200 Million by 2035The global Dengue Vaccines Market is expected to be reach USD 90.0 million in 2025 and is likely ...

Why Some Ideas Resist Spreading,” argues that notions get taken up not because of their virtue but because of their ...

Aurumin Limited has bagged high-grade hits in its first drilling program since 2013 at its Johnson Range project in the WA ...

The Government is making good progress on its exploration of supercritical geothermal as a potential energy source, with a governance group ...

GEN talked with several contract development and manufacturing organizations (CDMOs) and/or contract research organizations (CROs) about new ways they are addressing AAV manufacturing challenges.

GCF Cybersecurity Workforce Report highlights the importance of closing the talent gap for economic resilience and national ...